SecBot SecBot

BNTX

BioNTech SE
Nasdaq· Biological Products, (No Diagnostic Substances)· Inc. 2M· CIK 0001776985 Biotech & Drug Discovery
$85.26 −0.34 (−0.40%)
Nov 16 4:00 PM ET · prev $85.60
Market cap
$21.4B
Large cap
Consensus
Buy
69% Buy or better · 29 analysts
Median target
🔒 Subscribers only
1 year
−17.0%
from $102.67 · Nov 17
30 days
−4.4%
from $89.21
52-week range
$83.89–119.34
−29% from high · low Mar 10
Avg volume 20D
1.01M
shares / day
Short interest
2.25M
≈0.9% of shares · −1.2%
Days to cover
2.1
at average volume
Insider net
−$89.8M
0 buyers · 2 sellers · 12 mo
New fund stakes
3
Q2 2026 13F · 0 exits
Filing reports
26
analyzed by SecBot
SecBot read MIXED 17 reports · 90 days
Balance 4 bearish · 4 bullish · 1 mixed · 8 neutral oldest → newest, height = score
Avg score ·High conf. 13/17

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    2 insiders sold $89.8M.

  • InstitutionsBULLISH

    Q2 2026: 30 added (3 new), 19 trimmed or exited. Largest new: Assenagon Asset Management S.A $39.4M, Point72 Asset Management, $30.4M.

  • AnalystsBULLISH

    20 of 29 rate it Buy or better.

  • Short sellersSTEADY

    Short interest −1.2% to 2.25M shares. 2.1 days to cover, ≈0.9% of shares.

  • TrendDOWNTREND

    8% below its 50-day average.

  • SocialQUIET

    No Reddit mentions this week. Last mention Nov 9.

Who's buying

13F· Q2 2026
3
new positions
0
exits
$84.9M
in new stakes
FundMoveSharesValue
FMR LLCADD7,571,805$704.6M
FLOSSBACH VON STORCH SETRIM2,226,138$207.1M
BAILLIE GIFFORD & COTRIM592,380$55.1M
GOLDMAN SACHS GROUP INCDOUBLED589,903$54.9M
BANK OF AMERICA CORP /DE/TRIM486,205$45.2M
BALYASNY ASSET MANAGEMENT L.P.DOUBLED463,163$43.1M
Assenagon Asset Management S.A.NEW423,263$39.4M
D. E. Shaw & Co., Inc.DOUBLED417,421$38.8M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

29 analysts
Buy 69% rate it Buy or better
Strong Buy6Buy14Hold9Sell0Strong Sell0

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access
Recent actions
DateFirmActionRating
Nov 9, 2026HC Wainwright & Co.
MAINTAIN
MAINTAINBuy
Nov 4, 2026UBS
MAINTAIN
MAINTAINBuy
Nov 4, 2026Morgan Stanley
MAINTAIN
MAINTAINOverweight
Nov 4, 2026Wells Fargo
MAINTAIN
MAINTAINOverweight
Nov 4, 2026Evercore ISI Group
MAINTAIN
MAINTAINOutperform
Oct 14, 2026Canaccord Genuity
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
$0
bought · 0 insiders
$89.8M
sold · 2 insiders
DateInsiderTypeValue
Oct 9, 2026
Sahin Ugur
Chief Executive Officer
Oct 9, 2026
SELL$3.5M
Oct 8, 2026
Sahin Ugur
Chief Executive Officer
Oct 8, 2026
SELL$2.5M
Oct 7, 2026
Sahin Ugur
Chief Executive Officer
Oct 7, 2026
SELL$2.3M
Oct 6, 2026
Sahin Ugur
Chief Executive Officer
Oct 6, 2026
SELL$2.0M
Oct 5, 2026
Sahin Ugur
Chief Executive Officer
Oct 5, 2026
SELL$7.0M
Oct 2, 2026
Sahin Ugur
Chief Executive Officer
Oct 2, 2026
SELL$1.6M
Oct 1, 2026
Sahin Ugur
Chief Executive Officer
Oct 1, 2026
SELL$1.7M
Sep 30, 2026
Sahin Ugur
Chief Executive Officer
Sep 30, 2026
SELL$3.1M

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q-$1.89-$1.89–-$1.89-11.2%$153.6M
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Washington

Corporate Lobbying

8 lobbying filings and 0 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Short side

FINRA· Oct 30, 2026
2,245,589
shares short
-1.2%
vs prior settlement
2.1
days to cover
≈0.9%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
7 drugs tracked · Drug pipeline →
Recent

SecBot reports

26 filings · 12 press releases · 4 bullish · 5 bearish · 4 mixed · 13 neutral
All BNTX filing & press-release reports (38)